AKT1 and plasma cell myeloma: In multiple myeloma cells, NAT10 acetylates and stabilizes BCL-XL mRNA, which leads to elevated expression of BCL-XL, inhibiting apoptosis and activating the PI3K-AKT pathway, thereby promoting cell cycle progression and proliferation during multiple myeloma malignancy [26].